Axel Baumgarten

3.0k total citations
78 papers, 1.2k citations indexed

About

Axel Baumgarten is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Axel Baumgarten has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 40 papers in Epidemiology and 30 papers in Infectious Diseases. Recurrent topics in Axel Baumgarten's work include Hepatitis C virus research (47 papers), Liver Disease Diagnosis and Treatment (27 papers) and Hepatitis B Virus Studies (24 papers). Axel Baumgarten is often cited by papers focused on Hepatitis C virus research (47 papers), Liver Disease Diagnosis and Treatment (27 papers) and Hepatitis B Virus Studies (24 papers). Axel Baumgarten collaborates with scholars based in Germany, United States and United Kingdom. Axel Baumgarten's co-authors include Stefan Mauss, Thomas A. Lutz, Christoph Boesecke, Patrick Ingiliz, Jürgen K. Rockstroh, Dirk Engelbert, Ralph Wäsch, Dominik Schnerch, Knud Schewe and Stefan Christensen and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Axel Baumgarten

75 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Baumgarten Germany 19 718 671 571 279 142 78 1.2k
E. Gower Switzerland 5 1.8k 2.5× 1.7k 2.5× 444 0.8× 79 0.3× 71 0.5× 5 2.0k
Bach‐Nga Pham France 16 394 0.5× 461 0.7× 104 0.2× 105 0.4× 20 0.1× 44 1.0k
Jan‐Christian Wasmuth Germany 16 173 0.2× 274 0.4× 185 0.3× 139 0.5× 156 1.1× 46 712
Sarah Maylin France 23 1.9k 2.7× 2.0k 2.9× 321 0.6× 113 0.4× 27 0.2× 76 2.2k
Jay Lalezari United States 9 432 0.6× 398 0.6× 362 0.6× 191 0.7× 43 0.3× 11 801
Jacinta A. Holmes Australia 20 629 0.9× 612 0.9× 105 0.2× 42 0.2× 15 0.1× 51 947
S. Zaltron Italy 11 777 1.1× 728 1.1× 325 0.6× 75 0.3× 99 0.7× 23 937
G. Antonucci Italy 12 337 0.5× 495 0.7× 294 0.5× 106 0.4× 33 0.2× 36 655
Kathryn Razavi‐Shearer United States 7 1.5k 2.1× 1.4k 2.1× 207 0.4× 27 0.1× 13 0.1× 14 1.7k
Takeshi Sodeyama Japan 13 1.4k 1.9× 1.3k 1.9× 123 0.2× 34 0.1× 16 0.1× 42 1.7k

Countries citing papers authored by Axel Baumgarten

Since Specialization
Citations

This map shows the geographic impact of Axel Baumgarten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Baumgarten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Baumgarten more than expected).

Fields of papers citing papers by Axel Baumgarten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Baumgarten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Baumgarten. The network helps show where Axel Baumgarten may publish in the future.

Co-authorship network of co-authors of Axel Baumgarten

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Baumgarten. A scholar is included among the top collaborators of Axel Baumgarten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Baumgarten. Axel Baumgarten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pozniak, Anton, Chloe Orkin, Axel Baumgarten, et al.. (2025). Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV. Infectious Diseases and Therapy. 14(6). 1201–1217. 1 indexed citations
2.
Boesecke, Christoph, Axel Baumgarten, Christian Hoffmann, et al.. (2024). Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men. Infection. 53(1). 61–70. 5 indexed citations
3.
Fiebig, Uwe, Andrea Hauser, Uwe Koppe, et al.. (2023). Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020. BMC Infectious Diseases. 23(1). 673–673. 4 indexed citations
4.
Bickel, Markus, Christian Hoffmann, Eva Wolf, et al.. (2020). High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study. Infection. 48(3). 453–461. 10 indexed citations
5.
Baumgarten, Axel, et al.. (2020). Häufigkeiten von Patienten mit HIV in der ambulanten Versorgung in Deutschland – Eine Analyse auf Basis von Sekundärdaten. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(10). 1250–1261. 2 indexed citations
6.
7.
Ehret, Robert, Hauke Walter, Patrick Ingiliz, et al.. (2014). Safety analysis of raltegravir/truvada regimen in HIV/HCV co‐infected patients without switchback after HCV treatment. Journal of the International AIDS Society. 17(4S3). 19644–19644. 1 indexed citations
8.
Wolf, Eva, Axel Baumgarten, Christoph Stephan, et al.. (2014). 144‐week outcomes of lopinavir/ritonavir (LPV/r)‐based first‐line ART in 1,409 HIV‐infected patients: data from the German STAR/STELLA cohort. Journal of the International AIDS Society. 17(4S3). 19770–19770. 2 indexed citations
9.
Ingiliz, Patrick, et al.. (2014). Acute hepatitis C virus (HCV) infection in the setting of HIV coinfection: a single‐centre 10‐year follow‐up. Journal of the International AIDS Society. 17(4S3). 19638–19638. 2 indexed citations
10.
Mandorfer, Mattias, Karin Neukam, Thomas Reiberger, et al.. (2013). The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients. AIDS. 27(17). 2707–2714. 9 indexed citations
11.
Krämer, Benjamin, Hans Dieter Nischalke, Christoph Boesecke, et al.. (2013). Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C. AIDS. 27(17). 2817–2819. 14 indexed citations
12.
Vogel, M., Emma Page, Christoph Boesecke, et al.. (2011). Liver Fibrosis Progression After Acute Hepatitis C Virus Infection in HIV-Positive Individuals. Clinical Infectious Diseases. 54(4). 556–559. 26 indexed citations
13.
Hueppe, D., C John, R Heyne, et al.. (2010). Estimating the likelihood of sustained virological response in chronic hepatitis C therapy. Journal of Viral Hepatitis. 18(4). e81–90. 19 indexed citations
14.
Nischalke, Hans Dieter, Martin Vogel, Stefan Mauss, et al.. (2010). The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection. AIDS. 24(13). 2001–2007. 13 indexed citations
15.
Witthoeft, T., D. Hueppe, C John, et al.. (2010). Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study. Journal of Viral Hepatitis. 17(7). 459–68. 23 indexed citations
16.
Wolf, Eckhard, et al.. (2008). Similar virological response rates for ART-naïve subjects starting KVX + LPV/r or TVD+ LPV/r. Data from the prospective observational STAR cohort. Journal of the International AIDS Society. 11(S1). 1 indexed citations
17.
Streeck, Hendrik, Heiko Jessen, Bin Li, et al.. (2008). Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome. AIDS. 23(2). 259–262. 1 indexed citations
18.
Danta, Mark, Oliver G. Pybus, Sanjay Bhagani, et al.. (2007). Evidence of international transmission of HCV in pan-European study of HIV-positive men who have sex with men (MSM). Hepatology. 46. 1 indexed citations
19.
Engelbert, Dirk, Dominik Schnerch, Axel Baumgarten, & Ralph Wäsch. (2007). The ubiquitin ligase APCCdh1 is required to maintain genome integrity in primary human cells. Oncogene. 27(7). 907–917. 94 indexed citations
20.
Vogel, M., B Bieniek, Heiko Jessen, et al.. (2005). Treatment of acute hepatitis C infection in HIV‐infected patients: a retrospective analysis of eleven cases. Journal of Viral Hepatitis. 12(2). 207–211. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Gower Breakdown of academic impact, for papers by Bach‐Nga Pham Breakdown of academic impact, for papers by Jan‐Christian Wasmuth Breakdown of academic impact, for papers by Sarah Maylin Breakdown of academic impact, for papers by Jay Lalezari Breakdown of academic impact, for papers by Jacinta A. Holmes Breakdown of academic impact, for papers by S. Zaltron Breakdown of academic impact, for papers by G. Antonucci Breakdown of academic impact, for papers by Kathryn Razavi‐Shearer Breakdown of academic impact, for papers by Takeshi Sodeyama
Rankless by CCL
2026